NOVA BIO-PHARMA HOLDINGS LIMITED

Active United Kingdom

Activities of head offices

284 employees website.com
Life sciences and medical technology Activities of head offices
N

NOVA BIO-PHARMA HOLDINGS LIMITED

Activities of head offices

Founded 22 May 2008 Active United Kingdom 284 employees website.com
Life sciences and medical technology Activities of head offices
Accounts Submitted 29 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 8 May 2026 Next due 22 May 2027 11 months remaining
Net assets £32M £15M 2024 year on year
Total assets £49M £6M 2024 year on year
Total Liabilities £17M £9M 2024 year on year
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for NOVA BIO-PHARMA HOLDINGS LIMITED (06600173), an active life sciences and medical technology company based in United Kingdom. Incorporated 22 May 2008. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type group
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£752.99k

Decreased by £11.90M (-94%)

Net Assets

£32.11M

Decreased by £15.17M (-32%)

Total Liabilities

£16.57M

Increased by £9.14M (+123%)

Turnover

£40.60M

Increased by £7.22M (+22%)

Employees

284

Increased by 50 (+21%)

Debt Ratio

34%

Increased by 20 (+143%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Karen Alison LeishmanSecretaryUnknownUnknown1 Jan 2024Active
Nova Nominees LimitedCorporate-directorUnited KingdomUnknown17 Nov 2014Active

Shareholders

Shareholders (13)

Peter John Pitt White
54.5%
30,000
Regina Teresa White
45.5%
25,000

Persons with Significant Control

Persons with Significant Control (6)

6 Active

Peter John Pitt White

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB May 1948
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent

Mr Christopher Andrew Muryn

British

Active
Notified 24 Nov 2025
Residence United Kingdom
DOB January 1965
Nature of Control
  • Ownership Of Shares 25 To 50 Percent As Trust
  • Voting Rights 25 To 50 Percent As Trust

Mr James Andrew Pitt White

British

Active
Notified 24 Nov 2025
Residence England
DOB September 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent As Trust
  • Voting Rights 25 To 50 Percent As Trust

Regina Teresa White

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB July 1951
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Nova Nominees Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Right To Appoint And Remove Directors As Firm

Dr Peter John Pitt White

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB May 1948
Nature of Control
  • Ownership Of Shares 25 To 50 Percent As Trust
  • Voting Rights 25 To 50 Percent As Trust

Group Structure

Group Structure

NOVA NOMINEES LIMITED united kingdom
NOVA BIO-PHARMA HOLDINGS LIMITED Current Company

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 May 2026MortgageMortgage Satisfy Charge Full
8 May 2026Confirmation StatementConfirmation statement made on 8 May 2026 with updates
29 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
27 Nov 2025Persons With Significant ControlChristopher Andrew Muryn notified as a person with significant control
27 Nov 2025Persons With Significant ControlChange to Dr Peter John Pitt White as a person with significant control on 24 Nov 2025
27 May 2026 Mortgage

Mortgage Satisfy Charge Full

8 May 2026 Confirmation Statement

Confirmation statement made on 8 May 2026 with updates

29 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

27 Nov 2025 Persons With Significant Control

Christopher Andrew Muryn notified as a person with significant control

27 Nov 2025 Persons With Significant Control

Change to Dr Peter John Pitt White as a person with significant control on 24 Nov 2025

Recent Activity

Latest Activity

Mortgage Satisfy Charge Full

2 days ago on 27 May 2026

Confirmation statement made on 8 May 2026 with updates

3 weeks ago on 8 May 2026

Annual accounts made up to 31 Mar 2025

5 months ago on 29 Dec 2025

Christopher Andrew Muryn notified as a person with significant control

6 months ago on 27 Nov 2025

Change to Dr Peter John Pitt White as a person with significant control on 24 Nov 2025

6 months ago on 27 Nov 2025